GALWAY, Ireland--(BUSINESS WIRE)--Vivasure Medical ®, a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced the first patient treated with PerQseal ® ...
GALWAY, Ireland--(BUSINESS WIRE)--Vivasure Medical ®, a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced that it will unveil the results of its U.S ...
The "Surgical Wound Closure Devices Market – Global Outlook and Forecast 2021-2026" report has been added to ResearchAndMarkets.com’s offering. In-depth Analysis and Data-driven Insights on the Impact ...
For Vivasure Medical, good things come in twos. In tandem with its announcement this week that the FDA has greenlit a pivotal study of its PerQseal arterial closure device, the Irish devicemaker also ...
WASHINGTON, DC—For vascular closure after transfemoral TAVI, a strategy that combines suture- and plug-based devices halves the risk of access site-related vascular complications during a patient’s’ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results